HALOZYME THERAPEUTICS, INC. - COM (HALO)

Q2 2021 13F Holders as of 6/30/2021

Type / Class
Equity / COM
Number of holders
309
Total Shares
129M
Shares change
-2.16M
Total reported value, excl. options
$5.84B
Value change
-$91.2M
Put/Call ratio
0.96
Number of buys
146
Number of sells
-150
Price
$45.41
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.